Oncology

4 articles in this category

Circulating Tumor DNA Enables Minimal Residual Disease Detection and Precision Oncology

Words by Yuriy Poteshkin, MD, phD

Liquid biopsy through circulating tumor DNA (ctDNA) analysis matured as a powerful tool for minimal residual disease detection, treatment response monitoring, and early recurrence prediction across...

Dec 31, 2025Read more

circulating tumor DNActDNAliquid biopsy

CAR-T Cell Therapy and Checkpoint Inhibitors Advance Precision Cancer Immunotherapy

Words by Yuriy Poteshkin, MD, phD

Chimeric antigen receptor T cell (CAR-T) therapy and immune checkpoint inhibitors continued their evolution from hematologic malignancies toward solid tumors, with 2025 bringing significant advances...

Dec 31, 2025Read more

trends of the year 2025CAR-T cell therapycheckpoint inhibitors

Single-Dose HPV Vaccination Achieves Non-Inferiority for Cervical Cancer Prevention

Words by Yuriy Poteshkin, MD, phD

The ESCUDDO randomized trial demonstrated that a single dose of either bivalent or nonavalent human papillomavirus (HPV) vaccine provides equivalent protection against persistent cervical HPV...

Dec 29, 2025Read more

HPV vaccinehuman papillomaviruscervical cancer prevention

Circulating Tumor DNA-Guided Precision Oncology Transforms Bladder Cancer Treatment

Words by Yuriy Poteshkin, MD, phD

Liquid biopsy technology using circulating tumor DNA (ctDNA) emerged as a transformative biomarker-driven approach to personalized cancer therapy. The IMvigor011 trial demonstrated that ctDNA...

Dec 29, 2025Read more

bladder cancercirculating tumor DNActDNA